Press Release Details

Stereotaxis to Present at Leerink Swann & Company Rhythm Revival: Atrial Fibrillation Roundtable Conference

06/04/07 at 8:05 AM EDT
PDF Version
ST. LOUIS, Mo., June 4, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that James M. Stolze, Chief Financial Officer, and Ruchir Sehra, M.D., Chief Medical Officer, will present at the Leerink Swann & Company Rhythm Revival: Atrial Fibrillation Roundtable at The Grand Hyatt New York, on June 6, 2007, at 1:15 p.m. Eastern Time.

The audio presentation will be webcast live and remain available for 90 days thereafter at:

http://www.wsw.com/webcast/leerink10/stxs/

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire. All core components of the Stereotaxis System have received regulatory clearance in the U.S., Canada, and Europe.

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward- looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. 

    Contacts:

    Stereotaxis, Inc.                      Russo Partners
    314-678-6105                           Matthew Haines (Investors)
    Jim Stolze, Chief Financial Officer    212-845-4235
    jstolze@stereotaxis.com                Matthew.Haines@russopartnersllc.com

    Benjamin Carmichael (Media)
    212-845-4242
    Benjamin.Carmichael@russopartnersllc.com

SOURCE Stereotaxis, Inc. 

Jim Stolze, Chief Financial Officer of Stereotaxis, Inc., +1-314-678-6105, or
jstolze@stereotaxis.com; or Investors, Matthew Haines, +1-212-845-4235, or
Matthew.Haines@russopartnersllc.com, or Media, Benjamin Carmichael, +1-212-845-4242,
or Benjamin.Carmichael@russopartnersllc.com, both of Russo Partners

http://www.wsw.com/webcast/leerink10/stxs

Innovation Day